An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Baseline Characteristics Reported from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH Spruce Biosciences, Inc., today reported baseline characteristics of patients enrolled in the CAHmelia-203 and CAHmelia-204 clinical studies of tildacerfont for the treatment of adult classic congenital adrenal hyperplasia (CAH)....
Author: Mark Newman
J. Larry Jameson, MD, PhD, was named interim president of the University of Pennsylvania in a unanimous motion by the school’s board of trustees last month. Jameson had previously served as dean of Penn’s Perelman School of Medicine. “Penn is a remarkable institution that I am honored and humbled to lead and serve,” Jameson says. “Penn, like...Endocrine Society Applauds Ohio Governor Veto of State Ban on Gender-affirming Care for Minors
The Endocrine Society applauds Governor Mike Dewine’s veto of a proposed Ohio law that would have banned gender-affirming care for minors. The bill he vetoed contradicts mainstream medical practice and scientific evidence and would have taken medical decision-making out of the hands of families and their physicians and instead relied upon government officials. More than...
Endocrine Society member Tina Gupta, MD, always possessed a passion for helping her patients with type 1 diabetes overcome their daily struggles. She gives Endocrine News an exclusive account of why she made the move to the biotech industry by joining Vertex Pharmaceuticals, thus ensuring that her enthusiasm for patient-centered care can now help as...
For the ninth year running, Endocrine News talks to editors from Endocrine Society publications to unearth the endocrine nuggets of 2023. Here, the editors of Endocrinology weigh in on what they think qualify as the year’s biggest discoveries in endocrine science. Endocrinology Editor-in-Chief Carol A. Lange, PhD, professor of medicine (Division of Hematology, Oncology, and...
Fact Check: Endocrine Society Responds to Republican Debate Misinformation
The statement Florida Gov. Ron DeSantis made during Wednesday’s Republican presidential debate contradicts mainstream medical practice and scientific evidence. DeSantis’ comments characterizing gender-affirming care for transgender and gender-diverse youth as child abuse and genital mutilation do not reflect the healthcare landscape. Contrary to widespread misinformation, gender-affirming genital surgery is rarely offered to anyone under the...
Government Shutdown Averted for Second Time as Society Advocates to Fund Health, Research Programs With the clock running out on a federal government shutdown that was to begin midnight November 17, Congress passed a short-term bill to keep the government open. The bill will fund most health programs, including the National Institutes of Health (NIH),...
For the ninth year running, Endocrine News talks to editors from Endocrine Society publications to unearth the endocrine nuggets of 2023. Here, the editors of the Endocrine Reviews weigh in on what they think qualify as the year’s biggest discoveries in endocrine science. The endocrine Gold Rush of ’22 from last year’s issue might have...
